Baird Maintains Outperform on Concentrix, Lowers Price Target to $30

Benzinga Newsdesk www.benzinga.com Negative 94.3%

Neg 94.3% Neu 0% Pos 0%

Baird analyst David Koning maintains Concentrix (NASDAQ:CNXC) with a Outperform and lowers the price target from $40 to $30.